1. The Role of Interleukin-17A (IL-17A) in Depression
- Author
-
Mohammad Kazemi Arababadi, Mohammadreza Mirzabeigi, Hamid Hakimi, Javad Fathalizadeh, and Hanieh Fathalizadeh
- Subjects
0301 basic medicine ,Mechanism (biology) ,business.industry ,medicine.medical_treatment ,Context (language use) ,General Medicine ,medicine.disease_cause ,Review article ,Autoimmunity ,Pathogenesis ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Immune system ,Cytokine ,Immunology ,Medicine ,business ,030217 neurology & neurosurgery ,Depression (differential diagnoses) - Abstract
Context: The aim of this review was to address the recent data regarding the role of IL-17A in the pathogenesis of depression and its complications, such as cancer. Evidence Acquisition: This review article summarizes the recent data on the role of IL-17A in depression, using the PubMed and Google Scholar databases. Results: It has been documented that depression may alter the immune response via unknown mechanism/s. It is possible that immune responses and depression are linked via several molecules, including cytokines. IL-17A, a pro-inflammatory cytokine, participates in the pathogenesis of several inflammatory-based diseases, such as autoimmunity. Conclusions: Due to the comorbidity of depression and chronic inflammatory processes, and depression’s effect on the immune system, it may be hypothesized that the IL-17A cytokine plays a key role in the pathogenesis of depression.
- Published
- 2016
- Full Text
- View/download PDF